Om Meghashree Pharmaceuticals completes IPO allotment
KATHMANDU: Om Meghashree Pharmaceuticals, a medicine manufacturing company, has finalized the allotment of its Initial Public Offering (IPO). The share distribution was conducted through a formal event organized by the issue manager, Prabhu Capital.
The company opened its IPO for public subscription from February 11 to March 17, 2025 (Falgun 27 to Chaitra 3, 2081). Out of the applicants, 1,848,298 were deemed eligible. Of these, 147,600 applicants received 10 shares each, while 1,700,698 were left empty-handed. The IPO results will be available shortly on the Central Depository System and Clearing Limited (CDSC) website.
A total of 1,476,000 shares were issued to the public. Om Meghashree, known for producing and distributing various allopathic medicines, reported an accumulated loss of NPR 37.1 million as of mid-January 2025 (Poush end, 2081).
The company’s earnings per share stood at a mere NPR 0.98 for the same period, with a per-share net worth of NPR 91.15. Projections indicate that the accumulated loss will persist through the current fiscal year, raising concerns about the company’s financial health despite its entry into the stock market.
Facebook Comment